000 | 01215 a2200349 4500 | ||
---|---|---|---|
005 | 20250518090627.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a2059-0105 | ||
024 | 7 |
_a10.1038/s41541-020-0165-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMariz, Filipe Colaço | |
245 | 0 | 0 |
_aPeak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines. _h[electronic resource] |
260 |
_bNPJ vaccines _c2020 |
||
300 |
_a14 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aBender, Noemi | |
700 | 1 | _aAnantharaman, Devasena | |
700 | 1 | _aBasu, Partha | |
700 | 1 | _aBhatla, Neerja | |
700 | 1 | _aPillai, Madhavan Radhakrisna | |
700 | 1 | _aPrabhu, Priya R | |
700 | 1 | _aSankaranarayanan, Rengaswamy | |
700 | 1 | _aEriksson, Tiina | |
700 | 1 | _aPawlita, Michael | |
700 | 1 | _aPrager, Kristina | |
700 | 1 | _aSehr, Peter | |
700 | 1 | _aWaterboer, Tim | |
700 | 1 | _aMüller, Martin | |
700 | 1 | _aLehtinen, Matti | |
773 | 0 |
_tNPJ vaccines _gvol. 5 _gno. 1 _gp. 14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41541-020-0165-x _zAvailable from publisher's website |
999 |
_c30701803 _d30701803 |